Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Key drug trials from ACC.25 | Deaths after TAVR on the rise | FDA clears new device for heart access | Fake doc now in custody

News You Need to Know Today
Key drug trials from ACC.25 | Deaths after TAVR on the rise | FDA clears new device for heart access | Fake doc now in custody
Wednesday, April 9, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Late-breaking cardiovascular drug trials took center stage at ACC.25

Richard Kovacs, MD, detailed some the most important late-breaking cardiology pharmacology trials presented at ACC.25.

READ MORE >
Richard Kovacs, MD, MACC, chief medical officer, American College of Cardiology (ACC), former ACC president, and professor of clinical medicine, Indiana University School of Medicine, explains the most important late-breaking cardiology pharmacology trials at the ACC 2025 meeting. #ACC25 #ACC2025
Share on Twitter Share on Facebook Share on Linkedin

Late-breaking cardiovascular drug trials took center stage at ACC.25

Share on Twitter Share on Facebook Share on Linkedin
Richard Kovacs, MD, MACC, chief medical officer, American College of Cardiology (ACC), former ACC president, and professor of clinical medicine, Indiana University School of Medicine, explains the most important late-breaking cardiology pharmacology trials at the ACC 2025 meeting. #ACC25 #ACC2025
Richard Kovacs, MD, detailed some the most important late-breaking cardiology pharmacology trials presented at ACC.25.
READ MORE >

Deaths after TAVR are on the rise: Is the pandemic to blame or should cardiologists be concerned?

COVID-19 may help explain the increased rates of cardiac and noncardiac mortality among TAVR patients, but there are several other factors to consider as well. Researchers explored nearly 11 years of STS/ACC registry data to learn more.

READ MORE >
The Society of Cardiovascular Computed Tomography developed and published the new document to help educate healthcare providers who regularly treat acute chest pain in the emergency department (ED). 
Share on Twitter Share on Facebook Share on Linkedin

Deaths after TAVR are on the rise: Is the pandemic to blame or should cardiologists be concerned?

Share on Twitter Share on Facebook Share on Linkedin
The Society of Cardiovascular Computed Tomography developed and published the new document to help educate healthcare providers who regularly treat acute chest pain in the emergency department (ED). 
COVID-19 may help explain the increased rates of cardiac and noncardiac mortality among TAVR patients, but there are several other factors to consider as well. Researchers explored nearly 11 years of STS/ACC registry data to learn more.
READ MORE >

FDA clears new device for enabling access to the heart’s surface without an exposed needle

CardioVia's ViaOne technology includes a blunt-tip needle that remains concealed to help interventional cardiologists and electrophysiologists treat cardiac arrhythmias with a reduced risk of perforation or any other complications. 

READ MORE >
surgery.jpg
Share on Twitter Share on Facebook Share on Linkedin

FDA clears new device for enabling access to the heart’s surface without an exposed needle

Share on Twitter Share on Facebook Share on Linkedin
surgery.jpg
CardioVia's ViaOne technology includes a blunt-tip needle that remains concealed to help interventional cardiologists and electrophysiologists treat cardiac arrhythmias with a reduced risk of perforation or any other complications. 
READ MORE >

Man in custody after allegedly impersonating a cardiologist—at least 7 patients are dead

He is accused of claiming to be a cardiologist from London and performing heart surgeries at a hospital in India.

READ MORE >
doctor in handcuffs after being arrested
Share on Twitter Share on Facebook Share on Linkedin

Man in custody after allegedly impersonating a cardiologist—at least 7 patients are dead

Share on Twitter Share on Facebook Share on Linkedin
doctor in handcuffs after being arrested
He is accused of claiming to be a cardiologist from London and performing heart surgeries at a hospital in India.
READ MORE >

Featured Articles

Cardiologists perform world’s first TAVR procedures with new fully retrievable valve

Researchers detailed their experience performing the very first TAVR procedures with the Venus-PowerX TAVR valve from Venus MedTech. The valve includes a wire-controlled mechanism that makes it possible to recapture after full deployment. 

READ MORE >
Venus-PowerX TAVR valve developed by Venus MedTech
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists perform world’s first TAVR procedures with new fully retrievable valve

Share on Twitter Share on Facebook Share on Linkedin
Venus-PowerX TAVR valve developed by Venus MedTech
Researchers detailed their experience performing the very first TAVR procedures with the Venus-PowerX TAVR valve from Venus MedTech. The valve includes a wire-controlled mechanism that makes it possible to recapture after full deployment. 
READ MORE >

Electrophysiology Innovation at Texas Cardiac Arrhythmia Institute

Sponsored by Johnson & Johnson MedTech

Most advancements in electrophysiology technology are small and incremental, but the experts at Texas Cardiac Arrhythmia Institute in Austin, TX, were quick to see distinct advantages when they started using the latest iteration of radio frequency ablation, the QDOT MICRO™ Catheter.

READ MORE >
Biosense Electrophysiology
Share on Twitter Share on Facebook Share on Linkedin

Electrophysiology Innovation at Texas Cardiac Arrhythmia Institute

Sponsored by Johnson & Johnson MedTech

Share on Twitter Share on Facebook Share on Linkedin
Biosense Electrophysiology
Most advancements in electrophysiology technology are small and incremental, but the experts at Texas Cardiac Arrhythmia Institute in Austin, TX, were quick to see distinct advantages when they started using the latest iteration of radio frequency ablation, the QDOT MICRO™ Catheter.
READ MORE >

Shockwave Medical testing new-look IVL technology on challenging coronary lesions

Care teams throughout the U.S. and U.K. are now exploring the safety and effectiveness of using Shockwave Medical's new Javelin IVL catheters to treat challenging, difficult-to-cross coronary lesions. 

READ MORE >
Shockwave Medical IVL
Share on Twitter Share on Facebook Share on Linkedin

Shockwave Medical testing new-look IVL technology on challenging coronary lesions

Share on Twitter Share on Facebook Share on Linkedin
Shockwave Medical IVL
Care teams throughout the U.S. and U.K. are now exploring the safety and effectiveness of using Shockwave Medical's new Javelin IVL catheters to treat challenging, difficult-to-cross coronary lesions. 
READ MORE >

A simple way to ensure more heart patients with severe AS receive the care they need

Sending helpful alerts through email and the electronic health record can make a significant impact on patient care, according to new data presented at ACC.25 and published in Circulation.

READ MORE >
Tablet projecting metaphorical medical hologram
Share on Twitter Share on Facebook Share on Linkedin

A simple way to ensure more heart patients with severe AS receive the care they need

Share on Twitter Share on Facebook Share on Linkedin
Tablet projecting metaphorical medical hologram
Sending helpful alerts through email and the electronic health record can make a significant impact on patient care, according to new data presented at ACC.25 and published in Circulation.
READ MORE >

In Case You Missed It

FDA approves vutrisiran to treat ATTR-CM

The subcutaneous drug, sold under the brand name Amvuttra, joins an ATTR-CM market that already includes Pfizer’s tafamidis (Vyndaqel, Vyndamax) and BridgeBio’s acoramidis (Attruby).

READ MORE >
Alnylam Pharmaceuticals has received U.S. Food and Drug Administration (FDA) approval for vutrisiran, a subcutaneous injection the company sells under the brand name Amvuttra, to treat adult patients with transthyretin amyloid cardiomyopathy (ATTR-CM).
Share on Twitter Share on Facebook Share on Linkedin

FDA approves vutrisiran to treat ATTR-CM

Share on Twitter Share on Facebook Share on Linkedin
Alnylam Pharmaceuticals has received U.S. Food and Drug Administration (FDA) approval for vutrisiran, a subcutaneous injection the company sells under the brand name Amvuttra, to treat adult patients with transthyretin amyloid cardiomyopathy (ATTR-CM).
The subcutaneous drug, sold under the brand name Amvuttra, joins an ATTR-CM market that already includes Pfizer’s tafamidis (Vyndaqel, Vyndamax) and BridgeBio’s acoramidis (Attruby).
READ MORE >

Is statin therapy safe for pregnant women?

Laxmi Mehta, MD, explained that the use of statins when treating pregnant women is no longer forbidden. However, she added, cardiologists should always discuss it first with their patients.

READ MORE >
Laxmi Mehta explaining statins are no longer contraindicated for pregnant women
Share on Twitter Share on Facebook Share on Linkedin

Is statin therapy safe for pregnant women?

Share on Twitter Share on Facebook Share on Linkedin
Laxmi Mehta explaining statins are no longer contraindicated for pregnant women
Laxmi Mehta, MD, explained that the use of statins when treating pregnant women is no longer forbidden. However, she added, cardiologists should always discuss it first with their patients.
READ MORE >

First-in-class SAVR valve from Edwards Lifesciences linked to positive 5-year outcomes

Researchers focused on a relatively young patient population, hoping to learn as much as possible about the surgical valve's safety and effectiveness over an extended period of time. 

READ MORE >
Inspiris Resilia aortic valve from Edwards Lifesciences
Share on Twitter Share on Facebook Share on Linkedin

First-in-class SAVR valve from Edwards Lifesciences linked to positive 5-year outcomes

Share on Twitter Share on Facebook Share on Linkedin
Inspiris Resilia aortic valve from Edwards Lifesciences
Researchers focused on a relatively young patient population, hoping to learn as much as possible about the surgical valve's safety and effectiveness over an extended period of time. 
READ MORE >

In Other News

Criticisms over teleradiologist’s quick CT read convince jury to OK $15.5M malpractice verdict

Thomas J. Bryce, MD, purportedly only spent five minutes reading head and spine images of a 74-year-old who had experienced a fall, a fact harped on by winning plaintiff attorneys. 

READ MORE >
radiology clock alarm turnaround time efficiency
Share on Twitter Share on Facebook Share on Linkedin

Criticisms over teleradiologist’s quick CT read convince jury to OK $15.5M malpractice verdict

Share on Twitter Share on Facebook Share on Linkedin
radiology clock alarm turnaround time efficiency
Thomas J. Bryce, MD, purportedly only spent five minutes reading head and spine images of a 74-year-old who had experienced a fall, a fact harped on by winning plaintiff attorneys. 
READ MORE >

AI tool has 'untapped potential' for diagnosing and managing multiple sclerosis

The tool extracts brain region and white matter lesion volumes from any MRI of the brain, even less specialized sequences not traditionally used in the diagnosis or management of MS. 

READ MORE >
Multiple sclerosis ribbon MS
Share on Twitter Share on Facebook Share on Linkedin

AI tool has 'untapped potential' for diagnosing and managing multiple sclerosis

Share on Twitter Share on Facebook Share on Linkedin
Multiple sclerosis ribbon MS
The tool extracts brain region and white matter lesion volumes from any MRI of the brain, even less specialized sequences not traditionally used in the diagnosis or management of MS. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Hypertension | July 2020
New evidence that COVID-19 can infect heart cells | Faster cath lab activation times | CMS proposes TMVR updates
Practice Management | July 2020
STEMI care in the wake of COVID-19 | Infection & acute ischemic stroke | Statin use among healthy older patients
New polymer heart valve shows early potential | Cardiologist and war hero dies at 89 | Preterm births & ischemic heart disease
The Best of the Month: Infective endocarditis after TAVR | CAC scanning | COVID-19 | Revenue down 73%
Looming physician shortage will affect cardiology | Updates on MIPS participation | Statin use & COVID-19 patients

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …333
    • Page 334
    • Page 335
    • Page 336
    • Current page 337
    • Page 338
    • Page 339
    • Page 340
    • Page 341 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup